Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate
Francis Maria Bao Zambra et al.
HUMAN IMMUNOLOGY (2013)
Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer
Canan Kucukgergin et al.
DNA AND CELL BIOLOGY (2012)
The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer
Canan Kucukgergin et al.
GENE (2012)
CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma
Hsiu-Ting Tsai et al.
MEDICAL ONCOLOGY (2012)
Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study
LaCreis R. Kidd et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2012)
Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population
Andrew J. Gawron et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
The chemokine system in cancer biology and therapy
Alberto Mantovani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Chemokine polymorphisms and lymphoma: a pooled analysis
Paige M. Bracci et al.
LEUKEMIA & LYMPHOMA (2010)
Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer
Chia-Jui Weng et al.
ORAL ONCOLOGY (2010)
CCR5 Proinflammatory Allele in Prostate Cancer Risk
Carmela Rita Balistreri et al.
STEROID ENZYMES AND CANCER (2009)
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Richard M. Ransohoff
IMMUNITY (2009)
Control of Regulatory T Cell Lineage Commitment and Maintenance
Steven Z. Josefowicz et al.
IMMUNITY (2009)
Chemokine-chemokine receptors in cancer immunotherapy
Trina J. Stewart et al.
IMMUNOTHERAPY (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic Association of Monocyte Chemoattractant Protein 1 (MCP-1)-2518 Polymorphism in Mexican Patients With Transitional Cell Carcinoma of the Bladder
Luis Gabriel Vazquez-Lavista et al.
UROLOGY (2009)
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer
Pablo Saenz-Lopez et al.
BMC CANCER (2008)
RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women
Jyh-Ming Liou et al.
JOURNAL OF GASTROENTEROLOGY (2008)
SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer
Bijan Khademi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
CCR5 Δ32 polymorphism:: Associated with gallbladder cancer susceptibility
A. Srivastava et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine
Seung G. Kang et al.
GASTROENTEROLOGY (2007)
The chemokine network: A target in cancer biology?
Violet I. F. Slettenaar et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma
EJ Duell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
T cells and their partners: the chemokine dating agency
Antonella Viola et al.
TRENDS IN IMMUNOLOGY (2006)
T cell costimulation by chemokine receptors
B Molon et al.
NATURE IMMUNOLOGY (2005)
The Δ32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population
N Degerli et al.
CLINICAL BIOCHEMISTRY (2005)
Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer
A Zafiropoulos et al.
JOURNAL OF MEDICAL GENETICS (2004)